BioCentury
ARTICLE | Clinical News

Enbrel etanercept regulatory update

June 30, 2003 7:00 AM UTC

The FDA's Arthritis Advisory Committee voted 6-0 to recommend approval of Enbrel to treat ankylosing spondylitis (AS). Enbrel, a soluble TNF inhibitor, is marketed to treat psoriatic and rheumatoid ar...